This is HOPE
Breast Cancer is highly curable and it can be successfully treated if detected at an early stage. It can be even avoided through effective breast health education, awareness and prevention.
“Knowing My Normal” is the key component of the breast health awareness which is crucial to breast cancer risk prediction and early detection.
This is the heart of HOPE, the first smart breast health digital clinic on Smartphone, which will be available in October 2025 for all women over 25 and their primary healthcare providers.
This is MAMMOPE
MAMMOPE is an innovative AI-based ultrasound medical device, designed by Hope Valley AI with the support of the Design Spot Université Paris-Saclay, to address the issue of medical deserts by empowering primary healthcare providers with a smart non-operator-dependent ultrasound medical device.
It combines multimodal ultrasound with embedded AI to generate real-time, risk-informed breast imaging and a patented 4D digital twin of breast health. This enables continuous tracking of weak signals and offers a safe, radiation-free solution to support routine medical monitoring and preventive screening, used in complement and support of standard methods such as mammography and breast MRI.
This is IRISCREEN
IRISCREEN is a cutting-edge AI-assisted screening platform designed by HOPE VALLEY AI to help clinical researchers and healthcare providers to understand and address the silent cancer incubation challenge, years before cancer begins.
Powered by multi-scale risk-informed AI, IRISCREEN integrates multimodal data such as clinical, medical imaging, biological, and genetic data, to characterize new predictive risk markers and early detect weak signals of rare events’ incubation, long before symptoms appear.
Its first deployment targets pancreatic cancer, one of the deadliest cancers with a 5-year survival rate below 11% and a rising incidence in the World.
